This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 May;45(9):1283-1284.

doi: 10.1111/apt.14027.

Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum?

H H Shim^{1

2}, C H Seow^{1

3}

Affiliations

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.
² Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.
³ Department of Community Health Sciences, University of Calgary, Alberta, Canada.

PMID: 28370049
DOI: 10.1111/apt.14027

Editorial

Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum?

H H Shim et al. Aliment Pharmacol Ther. 2017 May.

. 2017 May;45(9):1283-1284.

doi: 10.1111/apt.14027.

Authors

H H Shim^{1

2}, C H Seow^{1

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.
² Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.
³ Department of Community Health Sciences, University of Calgary, Alberta, Canada.

PMID: 28370049
DOI: 10.1111/apt.14027

No abstract available

PubMed Disclaimer

Comment in

Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.
Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Mahadevan U, et al. Aliment Pharmacol Ther. 2017 May;45(9):1284. doi: 10.1111/apt.14054. Aliment Pharmacol Ther. 2017. PMID: 28370036 No abstract available.

Comment on

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.
Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Mahadevan U, et al. Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. doi: 10.1111/apt.13960. Epub 2017 Feb 7. Aliment Pharmacol Ther. 2017. PMID: 28169436

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information